Strategic risk-taking in India’s evolving pharma innovation ecosystem скачать в хорошем качестве

Strategic risk-taking in India’s evolving pharma innovation ecosystem

At the Economic Times RePharma Summit, industry stalwarts Dilip Shanghvi, Executive Chairman, Sun Pharmaceuticals; Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals; and Vikas Dandekar, Editor–ETPharma, The Economic Times, come together for a powerful trilogue on strategic risk-taking in India’s evolving pharma innovation ecosystem. The discussion explores how Indian pharma leaders are balancing global ambitions with R&D investments, navigating regulatory and pricing pressures, and making bold innovation bets in areas such as specialty drugs, biologics, and complex generics. With candid insights on capital allocation, partnerships, and long-term value creation, this session captures how calculated risks are shaping the next phase of India’s pharmaceutical growth story.